The USP 800 Guidelines have made the compounding of liquid formulations of NIOSH list medications more cumbersome and costly. Many institutions have updated facilities, revised standard operating procedures, and trained staff at much expense in order to continue to offer this service to their patients. For some, the high costs […]
Author: Joe Silva
Neonatal Clonidine Formulation
Through P&C’s collaboration with Akron Children’s Hospital in Ohio, a new neonatal clonidine formulation has been created using QuartetRx®. The formulation employs 0.3 mg clonidine tablets in water and simple syrup yielding a final concentration of 20 mcg/ml. Formulation and stability data presented at the 2019 ASHP Midyear meeting in […]
QuartetRX® Whole-Capsule Compounding
Exciting new developments in the whole-capsule compounding are on the horizon from P&C’s collaboration with CHU-Sainte Justine in Montréal, Canada. We have embarked on ground-breaking research using whole capsules in the compounding of hazardous drugs. Specifically, the team at CHU-Sainte Justine is exploring the use of QuartetRX in the compounding […]